ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $490,500 | -18.8% | 90,000 | 0.0% | 0.12% | -12.9% |
Q2 2023 | $603,900 | -24.1% | 90,000 | 0.0% | 0.13% | -27.5% |
Q1 2023 | $795,150 | +18.6% | 90,000 | 0.0% | 0.18% | +16.7% |
Q4 2022 | $670,365 | +1.6% | 90,000 | 0.0% | 0.16% | +6.8% |
Q3 2022 | $660,000 | -9.3% | 90,000 | 0.0% | 0.15% | -7.0% |
Q2 2022 | $728,000 | -41.7% | 90,000 | 0.0% | 0.16% | -36.2% |
Q1 2022 | $1,249,000 | -50.5% | 90,000 | 0.0% | 0.25% | -46.8% |
Q4 2021 | $2,525,000 | -17.5% | 90,000 | 0.0% | 0.46% | -22.5% |
Q3 2021 | $3,059,000 | -16.9% | 90,000 | 0.0% | 0.60% | -20.4% |
Q2 2021 | $3,682,000 | +1.6% | 90,000 | 0.0% | 0.75% | -2.7% |
Q1 2021 | $3,623,000 | -31.7% | 90,000 | 0.0% | 0.77% | -36.0% |
Q4 2020 | $5,303,000 | +21.2% | 90,000 | 0.0% | 1.20% | +19.6% |
Q3 2020 | $4,377,000 | +0.5% | 90,000 | 0.0% | 1.01% | +21.9% |
Q2 2020 | $4,354,000 | +59.8% | 90,000 | -10.0% | 0.83% | +39.8% |
Q1 2020 | $2,724,000 | – | 100,000 | – | 0.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
Triatomic Management LP | 121,166 | $813,024 | 0.83% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |